SEC Awards $88M to 3 Whistleblowers On March 19, 2018, the SEC issued an order authorizing $83M in whistleblower awards to three claimants and denying … Continued
Quiros to Pay $84 Million for EB-5 Investment Fraud On February 2, 2018, the U.S. Securities and Exchange Commission (SEC) announced an $84 million settlement … Continued
Tips for SEC Whistleblowers to Qualify for a Whistleblower Award Risk & Compliance magazine, which reports about international developments in corporate risk management and regulatory … Continued
Guide for Cybersecurity Whistleblowers Whistleblower lawyer Dallas Hammer has published a Practitioner’s Guide to Cybersecurity Whistleblowing. The guide can be downloaded here. The guide summarizes rewards and … Continued
A Law360 article titled “SEC Whistleblower Program Ain’t Broke — So Don’t ‘Fix’ It” quotes SEC whistleblower lawyer Jason Zuckerman about the success of the SEC … Continued
The 2017 Annual Report of the SEC Office of the Whistleblower reveals that the program is extraordinarily successful in enabling the SEC to protect investors … Continued
Reporting Improper Revenue Recognition to SEC Improper revenue recognition is the most common accounting violation targeted by the SEC. A January 2021 report issued … Continued
SEC Whistleblowers Denied Multimillion-Dollar Award On August 31, 2017, two whistleblowers appealed to the Second Circuit the SEC’s denial of a whistleblower award related … Continued
Leading SEC whistleblower attorney Jason Zuckerman was interviewed by Advisor Hub, a publication covering the wealth management industry, about a forthcoming announcement by the SEC of … Continued
J.P. Morgan Whistleblowers to Split $61 Million Award The SEC Whistleblower Office is set to announce its largest SEC whistleblower award to date – more … Continued
One Billion Reasons Why The SEC Whistleblower-Reward Program Is Effective The leading Sarbanes-Oxley whistleblower lawyers at Zuckerman Law have extensive experience representing corporate whistleblowers and have … Continued
In September 2015, Martin Shkreli became infamous after his company purchased the rights to an AIDS drug (Daraprim) and increased its price from $13.50 … Continued